Fig. 1.
Antifactor Xa activity at baseline and after administration of andexanet. ( A ) Patients on edoxaban with baseline antifactor Xa activity ≥40 ng/mL. ( B ) Patients on edoxaban with baseline antifactor Xa activity ≥75 ng/mL. The median antifactor Xa activity for each time point is marked as a horizontal line within the box. The bottom and top of the box denote the 25th and 75th percentiles, respectively. The lower and upper whiskers indicate the 10th and 90th percentiles, respectively. CI, confidence interval; N , number of patients with data.